Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Do Lockdowns Bring about Additional Mortality Benefits or Costs? Evidence based on Death Records from 300 Million Chinese People

Jinlei Qi, Dandan Zhang, Xiang Zhang, Peng Yin, Jiangmei Liu, Yuhang Pan, Tanakao Takana, Peiyu Xie, Zhaoguang Wang, Shuocen Liu, George F. Gao, Guojun He, Maigeng Zhou
doi: https://doi.org/10.1101/2020.08.28.20183699
Jinlei Qi
1National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Xicheng District, 100050 Beijing, China
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dandan Zhang
2National School of Development, Peking University, 5 Yiheyuan Road, Haidian District, 100871 Beijing, China
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiang Zhang
2National School of Development, Peking University, 5 Yiheyuan Road, Haidian District, 100871 Beijing, China
B.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peng Yin
1National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Xicheng District, 100050 Beijing, China
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiangmei Liu
1National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Xicheng District, 100050 Beijing, China
M.PH.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuhang Pan
3Division of Environment and Sustainability, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR, China
M.Phil.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tanakao Takana
4Division of Social Science, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR, China
M.Phil.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peiyu Xie
2National School of Development, Peking University, 5 Yiheyuan Road, Haidian District, 100871 Beijing, China
M.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhaoguang Wang
2National School of Development, Peking University, 5 Yiheyuan Road, Haidian District, 100871 Beijing, China
M.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuocen Liu
5Peking University HSBC Business School, Peking University, University Town, Nanshan District, 518055 Shenzhen, Guangdong Province, China
M.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George F. Gao
6Chinese Center for Disease Control and Prevention, 155 Changbai Road, Changping District, 102206 Beijing, China
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: zhoumaigeng@ncncd.chinacdc.cn gjhe@ust.hk gaofu@chinacdc.cn
Guojun He
3Division of Environment and Sustainability, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR, China
4Division of Social Science, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR, China
7Department of Economics, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR, China
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: zhoumaigeng@ncncd.chinacdc.cn gjhe@ust.hk gaofu@chinacdc.cn
Maigeng Zhou
1National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Xicheng District, 100050 Beijing, China
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: zhoumaigeng@ncncd.chinacdc.cn gjhe@ust.hk gaofu@chinacdc.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives To estimate the short-term effect of stringent lockdown policies on non-COVID-19 mortality and explore the heterogeneous impacts of lockdowns in China after the COVID-19 outbreak.

Design Employing a difference-in-differences method.

Setting Using comprehensive death records covering around 300 million Chinese people, we estimate the impacts of city and community lockdowns on non-COVID-19 mortality outside of Wuhan.

Participants 44,548 deaths recorded in 602 counties or districts by the Disease Surveillance Point System of the Chinese Center for Disease Control and Prevention from 1 January 2020 to14 March 2020.

Results We find that lockdowns reduced the number of non-COVID-19 deaths by 4.9% (cardiovascular deaths by 6.2%, injuries by 9.2%, and non-COVID-19 pneumonia deaths by 14.3%). A back-of-the-envelope calculation shows that more than 32,000 lives could have been saved from non-COVID-19 diseases/causes during the 40 days of the lockdown on which we focus.

Main outcome measures Weekly numbers of deaths from all causes without COVID-19, cardiovascular diseases, injuries, pneumonia, neoplasms, chronic respiratory diseases, and other causes were used to estimate the associations between lockdown policies and mortality.

Conclusions The results suggest that the rapid and strict virus countermeasures not only effectively controlled the spread of COVID-19 but also brought about unintended short-term public health benefits. The health benefits are likely driven by significant reductions in air pollution, traffic, and human interactions during the lockdown period. These findings can help better inform policymakers around the world about the benefits and costs of lockdowns policies in dealing with the COVID-19 pandemic.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The project is funded by the National Key R&D Program of China (2018YFC1315301), Peking University Research Grant (7100602966), Anti-epidemic Fund 2.0 from HK government, and HKUST School-Based Initiative (SBI17HS02).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All relevant ethical guidelines have been followed. There is not IRB/oversight body that directly relevant to this study.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The DSPs data are proprietary data owned by the Chinese CDC. They can be accessed through application to the National Center for Chronic and Noncommunicable Disease Control and Prevention (a subsidiary of the Chinese CDC). The codes necessary to re-produce all the tables in the paper are ready to submit to the journal as supplementary materials or to post on a public repository.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 13, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Do Lockdowns Bring about Additional Mortality Benefits or Costs? Evidence based on Death Records from 300 Million Chinese People
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Do Lockdowns Bring about Additional Mortality Benefits or Costs? Evidence based on Death Records from 300 Million Chinese People
Jinlei Qi, Dandan Zhang, Xiang Zhang, Peng Yin, Jiangmei Liu, Yuhang Pan, Tanakao Takana, Peiyu Xie, Zhaoguang Wang, Shuocen Liu, George F. Gao, Guojun He, Maigeng Zhou
medRxiv 2020.08.28.20183699; doi: https://doi.org/10.1101/2020.08.28.20183699
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Do Lockdowns Bring about Additional Mortality Benefits or Costs? Evidence based on Death Records from 300 Million Chinese People
Jinlei Qi, Dandan Zhang, Xiang Zhang, Peng Yin, Jiangmei Liu, Yuhang Pan, Tanakao Takana, Peiyu Xie, Zhaoguang Wang, Shuocen Liu, George F. Gao, Guojun He, Maigeng Zhou
medRxiv 2020.08.28.20183699; doi: https://doi.org/10.1101/2020.08.28.20183699

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Economics
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (559)
  • Anesthesia (135)
  • Cardiovascular Medicine (1778)
  • Dentistry and Oral Medicine (240)
  • Dermatology (173)
  • Emergency Medicine (317)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10834)
  • Forensic Medicine (8)
  • Gastroenterology (595)
  • Genetic and Genomic Medicine (2968)
  • Geriatric Medicine (289)
  • Health Economics (534)
  • Health Informatics (1938)
  • Health Policy (837)
  • Health Systems and Quality Improvement (747)
  • Hematology (295)
  • HIV/AIDS (634)
  • Infectious Diseases (except HIV/AIDS) (12535)
  • Intensive Care and Critical Care Medicine (697)
  • Medical Education (300)
  • Medical Ethics (89)
  • Nephrology (325)
  • Neurology (2819)
  • Nursing (152)
  • Nutrition (435)
  • Obstetrics and Gynecology (560)
  • Occupational and Environmental Health (600)
  • Oncology (1475)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (259)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (382)
  • Pediatrics (870)
  • Pharmacology and Therapeutics (368)
  • Primary Care Research (341)
  • Psychiatry and Clinical Psychology (2653)
  • Public and Global Health (5393)
  • Radiology and Imaging (1019)
  • Rehabilitation Medicine and Physical Therapy (599)
  • Respiratory Medicine (729)
  • Rheumatology (330)
  • Sexual and Reproductive Health (294)
  • Sports Medicine (280)
  • Surgery (329)
  • Toxicology (48)
  • Transplantation (151)
  • Urology (127)